A study on the use of safuf Musli Siyah for relieving symptoms in women after menopause

To evaluate the efficacy of safuf Musli Siyah (Curculigo orchioides Gaertn.) in the management of Post Menopausal Syndrome - Randomized placebo controlled clinical trial - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106516

Enrollment

Registered

2026-03-18

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R688- Other general symptoms and signs

Interventions

Intervention1: Musli Siyah(Curculigo orchioides Gaertn.): Safuf of Musli Siyah Dose 6gram orally per day (2gm TDS) with milk Control Intervention1: Corn starch: Corn starch Dose 6gram orally per da

Eligibility

Inclusion criteria

Inclusion criteria: patient the complete one year cessation of menstruation patient with age of 45 to 60 years. Serum FSH level more than 30 mIU per ML. Women experiencing symptoms in after natural and surgical Menopause. Both married and unmarried with post menopausal symptoms.

Exclusion criteria

Exclusion criteria: Women with post menopausal vaginal bleeding Women with any malignancy Patients with any critical illness

Design outcomes

Primary

Measure	Time frame
Change in total Menopausal rating scale score from baseline to end of treatmentTimepoint: Three months	—

Secondary

Measure	Time frame
Change in Menopausal rating scale sub scores and individual key symptomsTimepoint: Three months	—

Countries

India

Contacts

Public ContactDr Tabassum Aarfeen

Government Nizamia Tibbi College and General Hospital

drssntc@gmail.com9908624090

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026